NCT07218848
ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Trial completed
- Enrollment increased: 52 → 68 participants
- Study completion date changed from estimate of Apr 2027 to Oct 26, 2026
- Primary completion date changed from estimate of Apr 2027 to Oct 26, 2026
- Notable Eligibility criteria expanded, about 4 words
- Enrollment target: 52 to 68
- Primary completion date changed from estimate of Apr 2027 to Oct 26, 2026
- Study completion date: Apr 2027 to May 2027
- Minor Trial status changed: Recruiting → Active, Not Recruiting
- Primary and study completion pushed from Oct 2026 to Apr 2027
- Enrollment target: estimated 50 to confirmed 52
- Site details revised at 2 of 2 sites
- Study Status, Eligibilityv3
- Minor Start date changed from estimate of Oct 2025 to May 22, 2025v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arms and interventions
Aim 1: Quantitatively assess feasibility and acceptability of ProSalud and explore changes in cancer risk reduction behaviors. Aim 2: Qualitatively examine ways to optimize ProSalud. After Aim 1 follow-up is completed, we will recruit a subgroup of parent participants and conduct focus groups to further assess ProSalud with the goal of refining and optimizing our culturally tailored health promotion and cancer prevention workshop to best meet needs and preferences of Latino community members. Semi-structured focus group questions will derive from our quantitative findings in Aim 1.
Other: Aim 1 Workshops, Aim 2 Focus Groups
Sites
2 sites in 1 country